Xynomic Closed a Short Form Merger for "Going Private" Transaction
NEW YORK, New York and SHANGHAI, June 17, 2021 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, OTC: XYNO), a clinical stage US-China oncology drug development company, announced...